Kirkland & Ellis is advising R1 RCM, Skadden is advising a special committee of the R1 RCM Inc. in the transaction, while Wachtell, Lipton, Rosen &...
TowerBrook and CD&R’s $8.9 Billion Acquisition R1 RCM
Merck’s Acquisition of Eyebiotech
Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
Mirati Therapeutics’ Merger With Bristol Myers Squibb
Kirkland & Ellis LLP advised Bristol Myers Squibb, while Skadden, Arps, Slate, Meagher & Flom LLP advised Mirat on the deal. Bristol Myers Squibb (NYSE: BMY)...
Intercept Pharmaceuticals’ Merger With Alfasigma
Skadden, Arps, Slate, Meagher & Flom LLP served as legal counsel to Intercept, while Sullivan & Cromwell LLP and Chiomenti Studio Legale, as legal counsel to...
Astellas’ Acquisition of Iveric Bio
J.P. Morgan Securities LLC, acting through its affiliate JPMorgan Securities Japan Co., Ltd., acted as exclusive financial advisor to Astellas and Jones Day as Astellas’ legal...
Pfizer’s Acquisition of Seagen
Wachtell, Lipton, Rosen & Katz is acting as Pfizer’s legal advisor. Sullivan & Cromwell is serving as Seagen’s Board of Directors legal advisor. Skadden is advising...
AstraZeneca’s Acquisition of CinCor Pharma
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
Thoma Bravo’s $2.6 Billion Acquisition of Bottomline Technologies
Skadden, Arps, Slate, Meagher & Flom and Wilmer Cutler Pickering Hale and Dorr represented Bottomline, while Kirkland & Ellis represented Thoma Bravo in the transaction. Debevoise...
Novo Nordisk’s Acquisition of Dicerna Pharmaceuticals
Skadden, Arps, Slate, Meagher & Flom advised Dicerna Pharmaceuticals on the deal. Davis Polk & Wardwell advised Evercore. Dicerna Pharmaceuticals, Inc., has entered into a definitive agreement...